This inventor holds 1 USPTO granted patent and 1 EPO patent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2026
Title: José Antonio Encinar: Research on NRF2-Related Liver Disease
Introduction
José Antonio Encinar is an inventor associated with Elche, Spain. His patent work concerns a potential approach to treating fatty liver disease by inhibiting the interaction between NRF2 and β-TrCP.
Latest Patents
Encinar is associated with 1 patent: “Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease.” The invention describes inhibitors of the NRF2-β-TrCP interaction, including compounds of a specified general formula and their derivative salts. It proposes their use against NRF2-related diseases linked to chronic inflammation and oxidative stress, with particular attention to liver diseases such as fatty liver disease.
Career Highlights
The supplied information associates Encinar with the Spanish National Research Council (Consejo Superior de Investigaciones Científicas) and the Autonomous University of Madrid (Universidad Autónoma de Madrid). These institutions provide context for his research and patent activity.
Collaborations
The listed collaborators include Raquel Fernández Ginés and Manuela García López. Their names are associated with the patent information provided.
Conclusion
José Antonio Encinar’s patent work focuses on NRF2-β-TrCP interaction inhibitors as a potential treatment strategy for fatty liver disease and other conditions associated with inflammation and oxidative stress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile